Cargando…

Monitoring of CRT-D devices during radiation therapy in vitro

BACKGROUND: Using of active cardiac medical devices increases steadily. In Europe, there were 183 implants of ICD and 944 implants of PM, 119 of biventricular ICD and 41 of biventricular PM, all per million inhabitants in 2014. Healthcare environments, including radiotherapy treatment rooms, are con...

Descripción completa

Detalles Bibliográficos
Autores principales: Augustynek, Martin, Korpas, David, Penhaker, Marek, Cvek, Jakub, Binarova, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784340/
https://www.ncbi.nlm.nih.gov/pubmed/26960554
http://dx.doi.org/10.1186/s12938-016-0144-7
_version_ 1782420248045027328
author Augustynek, Martin
Korpas, David
Penhaker, Marek
Cvek, Jakub
Binarova, Andrea
author_facet Augustynek, Martin
Korpas, David
Penhaker, Marek
Cvek, Jakub
Binarova, Andrea
author_sort Augustynek, Martin
collection PubMed
description BACKGROUND: Using of active cardiac medical devices increases steadily. In Europe, there were 183 implants of ICD and 944 implants of PM, 119 of biventricular ICD and 41 of biventricular PM, all per million inhabitants in 2014. Healthcare environments, including radiotherapy treatment rooms, are considered challenging for these implantable devices. Exposure to radiation may cause the device to experience premature elective replacement indicator, decreased pacing amplitude or pacing inhibition, inappropriate shocks or inhibition of tachyarrhythmia therapy and loss of device function. These impacts may be temporary or permanent. The aim of this study was to evaluate the influence of linear accelerator ionizing radiation dose of 10 Gy on the activity of the biventricular cardioverter-defibrillator in different position in radiation beam. METHODS: Two identical wireless communication devices with all three leads were used for the measurement. Both systems were soused into solution saline and exposed in different position in the beam of linear accelerator per 10 Gy fractions. In comparison of usually used maximum recommended dose of 2 Gy, the radiation doses used in test were five times higher. Using the simultaneous monitoring wireless communication between device and its programmer allowed watching of the devices activities, noise occurrence or drop of biventricular pacing on the programmer screen, observed by local television loop camera. RESULTS: At any device position in radiation beam, there were no influences of the device activity at dose of 10 Gy neither a significant increase of a solution saline temperature in any of the measured positions of CRT-D systems in linear accelerator. CONCLUSIONS: The results of the study indicated, that the recommendation dose for treating the patients with implantable devices are too conservative and the risk of device failure is not so high. The systems can easily withstand the dose fractions of tens Gy, which would allow current single-dose-procedure treatment in radiation therapy. Even though the process of the random alteration of device memory and electrical components by scatter particles not allowed to specify a safe dose during ionizing radiation, this study showed that the safe limit are above the today used dose fractions.
format Online
Article
Text
id pubmed-4784340
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47843402016-03-10 Monitoring of CRT-D devices during radiation therapy in vitro Augustynek, Martin Korpas, David Penhaker, Marek Cvek, Jakub Binarova, Andrea Biomed Eng Online Research BACKGROUND: Using of active cardiac medical devices increases steadily. In Europe, there were 183 implants of ICD and 944 implants of PM, 119 of biventricular ICD and 41 of biventricular PM, all per million inhabitants in 2014. Healthcare environments, including radiotherapy treatment rooms, are considered challenging for these implantable devices. Exposure to radiation may cause the device to experience premature elective replacement indicator, decreased pacing amplitude or pacing inhibition, inappropriate shocks or inhibition of tachyarrhythmia therapy and loss of device function. These impacts may be temporary or permanent. The aim of this study was to evaluate the influence of linear accelerator ionizing radiation dose of 10 Gy on the activity of the biventricular cardioverter-defibrillator in different position in radiation beam. METHODS: Two identical wireless communication devices with all three leads were used for the measurement. Both systems were soused into solution saline and exposed in different position in the beam of linear accelerator per 10 Gy fractions. In comparison of usually used maximum recommended dose of 2 Gy, the radiation doses used in test were five times higher. Using the simultaneous monitoring wireless communication between device and its programmer allowed watching of the devices activities, noise occurrence or drop of biventricular pacing on the programmer screen, observed by local television loop camera. RESULTS: At any device position in radiation beam, there were no influences of the device activity at dose of 10 Gy neither a significant increase of a solution saline temperature in any of the measured positions of CRT-D systems in linear accelerator. CONCLUSIONS: The results of the study indicated, that the recommendation dose for treating the patients with implantable devices are too conservative and the risk of device failure is not so high. The systems can easily withstand the dose fractions of tens Gy, which would allow current single-dose-procedure treatment in radiation therapy. Even though the process of the random alteration of device memory and electrical components by scatter particles not allowed to specify a safe dose during ionizing radiation, this study showed that the safe limit are above the today used dose fractions. BioMed Central 2016-03-09 /pmc/articles/PMC4784340/ /pubmed/26960554 http://dx.doi.org/10.1186/s12938-016-0144-7 Text en © Augustynek et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Augustynek, Martin
Korpas, David
Penhaker, Marek
Cvek, Jakub
Binarova, Andrea
Monitoring of CRT-D devices during radiation therapy in vitro
title Monitoring of CRT-D devices during radiation therapy in vitro
title_full Monitoring of CRT-D devices during radiation therapy in vitro
title_fullStr Monitoring of CRT-D devices during radiation therapy in vitro
title_full_unstemmed Monitoring of CRT-D devices during radiation therapy in vitro
title_short Monitoring of CRT-D devices during radiation therapy in vitro
title_sort monitoring of crt-d devices during radiation therapy in vitro
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784340/
https://www.ncbi.nlm.nih.gov/pubmed/26960554
http://dx.doi.org/10.1186/s12938-016-0144-7
work_keys_str_mv AT augustynekmartin monitoringofcrtddevicesduringradiationtherapyinvitro
AT korpasdavid monitoringofcrtddevicesduringradiationtherapyinvitro
AT penhakermarek monitoringofcrtddevicesduringradiationtherapyinvitro
AT cvekjakub monitoringofcrtddevicesduringradiationtherapyinvitro
AT binarovaandrea monitoringofcrtddevicesduringradiationtherapyinvitro